Incentives and bargaining within the pharmaceutical benefits scheme

Millhouse, Kathryn. (2008). Incentives and bargaining within the pharmaceutical benefits scheme Honours Thesis, School of Economics, The University of Queensland.

       
Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
THE20774.pdf Full text application/pdf 4.27MB 22
Author Millhouse, Kathryn.
Thesis Title Incentives and bargaining within the pharmaceutical benefits scheme
School, Centre or Institute School of Economics
Institution The University of Queensland
Publication date 2008
Thesis type Honours Thesis
Total pages 91
Language eng
Subjects 14 Economics
Formatted abstract
This thesis aims to deliver an accurate description of the different components of the Pharmaceutical Benefits Scheme (PBS), along with an analysis of some of the elements that are specific to the bargaining dynamic between pharmaceutical companies and pharmacies. The main potential finding within this thesis is what determines the division of surplus between the players on the assumption that the pharmacy is the first to make an offer. Three exogenous variables, the PBS price of a drug, the number of pharmacies close by and the number of substitutes for a drug are assumed to determine the surplus, and the same three variables are used to model the bargaining discount rates. The Envelope Theorem is then applied to isolate the effects of independent changes in the parameters on the proportion of the surplus accrued by each player.

The relationship between pharmacies and drug companies has been modeled as an alternating offer game and the effect of a change in each individual variable on the share of the surplus accrued by the pharmacy has been recorded. It was found that the price of a PBS drug has a positive effect on the share of surplus received by the pharmacy, the number of pharmacies near by has a negative impact, while the number of substitutes is positively related to the accrued surplus by the pharmacy. The description of the PBS system, including the incentives faced by all involved parties (patients, doctors, pharmacies, drug companies and the Government) might be of wider interest beyond the Australian context, given the prevalence of drug subsidy systems in OECD countries. Such a description does not seem to exist in the Australian public arena.

Document type: Thesis
Collection: UQ Theses (non-RHD) - UQ staff and students only
 
Citation counts: Google Scholar Search Google Scholar
Created: Fri, 01 Oct 2010, 12:47:20 EST by Muhammad Noman Ali on behalf of Social Sciences and Humanities Library Service